Does TREMELIMUMAB Cause Off label use? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Off label use have been filed in association with TREMELIMUMAB (IMJUDO). This represents 1.8% of all adverse event reports for TREMELIMUMAB.
44
Reports of Off label use with TREMELIMUMAB
1.8%
of all TREMELIMUMAB reports
3
Deaths
28
Hospitalizations
How Dangerous Is Off label use From TREMELIMUMAB?
Of the 44 reports, 3 (6.8%) resulted in death, 28 (63.6%) required hospitalization, and 4 (9.1%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREMELIMUMAB. However, 44 reports have been filed with the FAERS database.
What Other Side Effects Does TREMELIMUMAB Cause?
Pyrexia (178)
Diarrhoea (136)
Death (116)
Colitis (115)
Pneumonitis (87)
Pneumonia (85)
Sepsis (82)
Vomiting (78)
Febrile neutropenia (72)
Malignant neoplasm progression (68)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TREMELIMUMAB Alternatives Have Lower Off label use Risk?
TREMELIMUMAB vs TREMELIMUMAB\TREMELIMUMAB-ACTL
TREMELIMUMAB vs TRENBOLONE
TREMELIMUMAB vs TREOSULFAN
TREMELIMUMAB vs TREPROSTINIL
TREMELIMUMAB vs TREPROSTINIL DIOLAMINE